Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma.

Rand V, Prebble E, Ridley L, Howard M, Wei W, Brundler MA, Fee BE, Riggins GJ, Coyle B, Grundy RG; Children's Cancer and Leukaemia Group Biological Studies Committee.

Br J Cancer. 2008 Oct 7;99(7):1136-43. doi: 10.1038/sj.bjc.6604651. Epub 2008 Sep 9.

PMID:
18781180
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.

Ward S, Harding B, Wilkins P, Harkness W, Hayward R, Darling JL, Thomas DG, Warr T.

Genes Chromosomes Cancer. 2001 Sep;32(1):59-66.

PMID:
11477662
[PubMed - indexed for MEDLINE]
3.

Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.

Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, Radlwimmer B, Lichter P.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2070-9.

PMID:
16609018
[PubMed - indexed for MEDLINE]
Free Article
4.

Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.

Lindsey JC, Lusher ME, Anderton JA, Gilbertson RJ, Ellison DW, Clifford SC.

Br J Cancer. 2007 Jul 16;97(2):267-74. Epub 2007 Jun 19.

PMID:
17579622
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma.

Tabori U, Wong V, Ma J, Shago M, Alon N, Rutka J, Bouffet E, Bartels U, Malkin D, Hawkins C.

Br J Cancer. 2008 Oct 7;99(7):1129-35. doi: 10.1038/sj.bjc.6604652. Epub 2008 Sep 16.

PMID:
18797459
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Isochromosome 1q as an early genetic event in a child with intracranial ependymoma characterized by molecular cytogenetics.

Granzow M, Popp S, Weber S, Schoell B, Holtgreve-Grez H, Senf L, Hager D, Boschert J, Scheurlen W, Jauch A.

Cancer Genet Cytogenet. 2001 Oct 1;130(1):79-83.

PMID:
11672779
[PubMed - indexed for MEDLINE]
7.

Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.

Lukashova-v Zangen I, Kneitz S, Monoranu CM, Rutkowski S, Hinkes B, Vince GH, Huang B, Roggendorf W.

Acta Neuropathol. 2007 Mar;113(3):325-37. Epub 2007 Jan 31.

PMID:
17265049
[PubMed - indexed for MEDLINE]
8.

Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases.

Komatsu K, Murata K, Kameyama M, Ayaki M, Mukai M, Ishiguro S, Miyoshi J, Tatsuta M, Inoue M, Nakamura H.

Oncology. 2002;63(2):192-200.

PMID:
12239456
[PubMed - indexed for MEDLINE]
9.

Upregulated expression of S100A6 in human gastric cancer.

Yang YQ, Zhang LJ, Dong H, Jiang CL, Zhu ZG, Wu JX, Wu YL, Han JS, Xiao HS, Gao HJ, Zhang QH.

J Dig Dis. 2007 Nov;8(4):186-93.

PMID:
17970874
[PubMed - indexed for MEDLINE]
10.

Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.

Peyre M, Commo F, Dantas-Barbosa C, Andreiuolo F, Puget S, Lacroix L, Drusch F, Scott V, Varlet P, Mauguen A, Dessen P, Lazar V, Vassal G, Grill J.

PLoS One. 2010 Sep 24;5(9):e12932. doi: 10.1371/journal.pone.0012932.

PMID:
20885975
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Cross-species genomics matches driver mutations and cell compartments to model ependymoma.

Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, Atkinson J, DeWire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG, Gilbertson RJ.

Nature. 2010 Jul 29;466(7306):632-6. doi: 10.1038/nature09173. Epub 2010 Jul 18.

PMID:
20639864
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).

Kilday JP, Mitra B, Domerg C, Ward J, Andreiuolo F, Osteso-Ibanez T, Mauguen A, Varlet P, Le Deley MC, Lowe J, Ellison DW, Gilbertson RJ, Coyle B, Grill J, Grundy RG.

Clin Cancer Res. 2012 Apr 1;18(7):2001-11. doi: 10.1158/1078-0432.CCR-11-2489. Epub 2012 Feb 14.

PMID:
22338015
[PubMed - indexed for MEDLINE]
Free Article
13.

Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.

Karakoula K, Suarez-Merino B, Ward S, Phipps KP, Harkness W, Hayward R, Thompson D, Jacques TS, Harding B, Beck J, Thomas DG, Warr TJ.

Genes Chromosomes Cancer. 2008 Nov;47(11):1005-22. doi: 10.1002/gcc.20607.

PMID:
18663750
[PubMed - indexed for MEDLINE]
14.

Expression of members of the S100 Ca2+-binding protein family in guinea-pig smooth muscle.

Daub B, Schroeter M, Pfitzer G, Ganitkevich V.

Cell Calcium. 2003 Jan;33(1):1-10.

PMID:
12526882
[PubMed - indexed for MEDLINE]
15.

Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.

Zawrocki A, Iżycka-Świeszewska E, Papierz W, Liberski PP, Zakrzewski K, Biernat W.

Folia Neuropathol. 2011;49(2):94-102. Review.

PMID:
21845537
[PubMed - indexed for MEDLINE]
16.

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.

Hulsebos TJ, Oskam NT, Bijleveld EH, Westerveld A, Hermsen MA, van den Ouweland AM, Hamel BC, Tijssen CC.

Br J Cancer. 1999 Dec;81(7):1150-4.

PMID:
10584875
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.

Gilbertson RJ, Bentley L, Hernan R, Junttila TT, Frank AJ, Haapasalo H, Connelly M, Wetmore C, Curran T, Elenius K, Ellison DW.

Clin Cancer Res. 2002 Oct;8(10):3054-64.

PMID:
12374672
[PubMed - indexed for MEDLINE]
Free Article
18.

Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EF, Massimino M, Sozzi G.

J Clin Oncol. 2006 Nov 20;24(33):5223-33.

PMID:
17114655
[PubMed - indexed for MEDLINE]
19.

Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.

Puget S, Grill J, Valent A, Bieche I, Dantas-Barbosa C, Kauffmann A, Dessen P, Lacroix L, Geoerger B, Job B, Dirven C, Varlet P, Peyre M, Dirks PB, Sainte-Rose C, Vassal G.

J Clin Oncol. 2009 Apr 10;27(11):1884-92. doi: 10.1200/JCO.2007.15.4195. Epub 2009 Mar 16.

PMID:
19289631
[PubMed - indexed for MEDLINE]
20.

Molecular staging of intracranial ependymoma in children and adults.

Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schöttler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S.

J Clin Oncol. 2010 Jul 1;28(19):3182-90. doi: 10.1200/JCO.2009.27.3359. Epub 2010 Jun 1.

PMID:
20516456
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk